Robert Petit - 22 Jan 2026 Form 4 Insider Report for OS Therapies Inc (OSTX)

Role
Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.
Signature
/s/ Robert Petit
Issuer symbol
OSTX
Transactions as of
22 Jan 2026
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 16:41:51 UTC
Previous filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
PETIT ROBERT Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated. C/O OS THERAPIES INCORPORATED, 115 PULLMAN CROSSING ROAD, SUITE 103, GRASONVILLE /s/ Robert Petit 13 Feb 2026 0001576077

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OSTX Common Stock 200,000 22 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSTX Stock options (right to buy) Award $0 +100,000 $0.000000 100,000 22 Jan 2026 Common Stock 100,000 $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 22, 2026, the reporting person was granted options to purchase 100,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date.

Remarks:

Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.